IRIS UniCatt

Sica, Simona
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 13.137
AS - Asia 10.722
EU - Europa 10.696
SA - Sud America 2.602
AF - Africa 374
OC - Oceania 192
Continente sconosciuto - Info sul continente non disponibili 15
Totale 37.738
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 12.675
SG - Singapore 5.060
DE - Germania 2.640
CN - Cina 2.639
BR - Brasile 2.115
IT - Italia 2.022
SE - Svezia 1.747
FR - Francia 713
GB - Regno Unito 685
IE - Irlanda 621
IN - India 576
UA - Ucraina 553
VN - Vietnam 499
ID - Indonesia 442
RU - Federazione Russa 315
FI - Finlandia 311
CA - Canada 266
AR - Argentina 192
ES - Italia 189
HK - Hong Kong 187
PL - Polonia 186
KR - Corea 184
AU - Australia 169
TR - Turchia 167
JP - Giappone 166
NL - Olanda 157
BD - Bangladesh 142
IQ - Iraq 133
MX - Messico 127
ZA - Sudafrica 86
AT - Austria 84
EC - Ecuador 73
IR - Iran 69
BE - Belgio 65
CI - Costa d'Avorio 59
CZ - Repubblica Ceca 56
SA - Arabia Saudita 53
VE - Venezuela 53
PK - Pakistan 49
CO - Colombia 46
EG - Egitto 45
MA - Marocco 43
RO - Romania 43
UZ - Uzbekistan 41
KE - Kenya 40
CH - Svizzera 38
BG - Bulgaria 34
PY - Paraguay 33
AE - Emirati Arabi Uniti 31
HU - Ungheria 30
CL - Cile 28
IL - Israele 28
NP - Nepal 28
LT - Lituania 27
NO - Norvegia 27
PT - Portogallo 27
DZ - Algeria 26
JO - Giordania 24
UY - Uruguay 24
TH - Thailandia 23
NZ - Nuova Zelanda 22
PE - Perù 22
TW - Taiwan 22
PH - Filippine 20
LB - Libano 19
AZ - Azerbaigian 18
GR - Grecia 18
MY - Malesia 18
SK - Slovacchia (Repubblica Slovacca) 15
ET - Etiopia 14
RS - Serbia 14
TN - Tunisia 13
BO - Bolivia 12
KZ - Kazakistan 12
DO - Repubblica Dominicana 11
JM - Giamaica 11
SN - Senegal 11
BA - Bosnia-Erzegovina 10
PA - Panama 10
AL - Albania 9
DK - Danimarca 9
HR - Croazia 9
AM - Armenia 8
BZ - Belize 8
QA - Qatar 8
TT - Trinidad e Tobago 8
LK - Sri Lanka 7
MD - Moldavia 7
OM - Oman 7
EU - Europa 6
GE - Georgia 6
KG - Kirghizistan 6
A2 - ???statistics.table.value.countryCode.A2??? 5
AO - Angola 5
BH - Bahrain 5
BY - Bielorussia 5
CR - Costa Rica 5
EE - Estonia 5
GA - Gabon 5
SY - Repubblica araba siriana 5
Totale 37.641
Salva come PNG Salva come JPEG
Città #
Singapore 2.077
Chandler 1.542
Ashburn 1.235
Dublin 606
Beijing 545
Jacksonville 411
Jakarta 400
Los Angeles 380
Milan 374
San Mateo 369
Hefei 341
Wilmington 307
Dearborn 304
Rome 299
Woodbridge 275
Ann Arbor 267
Nanjing 255
New York 253
Houston 246
Boston 235
Munich 233
Moscow 200
Redwood City 199
Hyderabad 190
São Paulo 190
Princeton 189
Dallas 187
Chicago 185
Seattle 184
Cattolica 174
Ho Chi Minh City 173
Frankfurt am Main 169
Hong Kong 163
Fairfield 161
Lancaster 137
Hanoi 130
Nürnberg 130
Lawrence 120
Buffalo 114
Redmond 114
Marseille 112
Oviedo 112
Nanchang 110
Seoul 109
Warsaw 102
Kent 96
Helsinki 92
Hangzhou 89
Toronto 89
Boardman 84
Bremen 84
The Dalles 83
Tokyo 79
Brooklyn 74
Izmir 73
Santa Clara 70
London 66
Tianjin 64
Florence 63
San Francisco 61
Brussels 60
Norwalk 60
Abidjan 59
Phoenix 59
Rio de Janeiro 59
Mountain View 58
Belo Horizonte 52
Nuremberg 52
Baghdad 50
Curitiba 50
Cambridge 49
Lappeenranta 49
Atlanta 48
Kunming 48
Hebei 47
Washington 46
Johannesburg 44
Pune 44
Shenyang 44
Denver 42
Dhaka 40
Naples 40
Zawidów 40
Zhengzhou 40
Amsterdam 39
Düsseldorf 39
Shanghai 39
Guangzhou 38
Stockholm 38
Montreal 37
Vienna 37
Mexico City 36
Porto Alegre 36
Sydney 36
Bologna 34
Buenos Aires 34
Changsha 34
Philadelphia 34
Tashkent 34
Busto Arsizio 33
Totale 17.533
Salva come PNG Salva come JPEG
Nome #
VITAMIN B12 DEFICIENCY: CORRELATION BETWEEN MTHFR POLYMORPHISMS AND CLINICAL AND LABORATORY FINDINGS 2.904
HIGH-DOSE CHEMOTHERAPY WITH AUTOLOGOUS STEM CELL TRANSPLANTATION IN FIRST LINE TREATMENT FOR HIGH-RISK DIFFUSE LARGE B CELL LYMPHOMA (DLBCL) IN THE RITUXIMAB ERA: AN INTENTION TO TREAT-ANALYSIS 403
Reliability of leukostasis grading score to identify patients with high-risk hyperleukocytosis 350
Elevated lactate dehydrogenase has prognostic relevance in treatment-naïve patients affected by chronic lymphocytic leukemia with trisomy 12 316
Dasatinib first-line: Multicentric Italian experience outside clinical trials 283
Dasatinib first-line: Multicentric Italian experience outside clinical trials 280
comparison of haploidentical bone marrow versus matchet unrelated donor peripheral blood stem cell transplantation with posttransplant cyclophosphamide in patients with acute leukemia 277
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 274
Salivary proteomic analysis and acute graft versus host disease after allogeneic hematopoietic stem cell transplantation 215
Management of infection in PNH patients treated with eculizumab or other complement inhibitors: Unmet clinical needs 207
Severe veno-occlusive disease after autologous peripheral blood stem cell transplantation for high-grade non-Hodgkin lymphoma: report of a successfully managed case and a literature review of veno-occlusive disease. 201
A machine-learning parsimonious multivariable predictive model of mortality risk in patients with Covid-19 199
Comparison between oral and intravenous fludarabine plus cyclophosphamide regime as front-line therapy in patients affected by chronic lymphocytic leukaemia: influence of biological parameters on the clinical outcome 194
Prospective study of hepatitis B virus reactivation in patients with hematological malignancies 191
Correlation between paraproteinaemia and viral reactivation after allo-SCT 185
in Higher-Risk Myelodysplastic Syndromes and Low Blast Count Acute Myeloid Leukemia: Results of the BMT-AZA Prospective Study 184
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: safety and efficacy evaluation 180
Serum of healthy donors receiving granulocyte colony-stimulating factor induces T cell unresponsiveness 178
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation. 176
Increased risk of acute myeloid leukaemia due to polymorphisms in detoxification and DNA repair enzymes. 174
Carbapenemase-producing Klebsiella pneumoniae and hematologic malignancies 174
MTHFR polymorphysms in myelodysplastic syndromes and therapy-related myeloid neoplasms 173
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the italian network on secondary leukemias. 170
Bendamustine in combination with rituximab for elderly patients with previously untreated B-cell chronic lymphocytic leukemia: A retrospective analysis of real-life practice in Italian hematology departments 166
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 164
Prospective evaluation of Epstein-Barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 161
Efficacy of lenalidomide plus dexamethasone for POEMS syndrome relapsed after autologous peripheral stem-cell transplantation 161
Low-dose valganciclovir as preemptive therapy for cytomegalovirus infection occurring in allogeneic stem cell transplant recipients 160
The role of HLA--G 14-bp polymorphism in allo-HSCT after short-term course MTX for GvHD prophylaxis 159
Dose-Dependent Effect of Granulocyte Transfusions in Hematological Patients with Febrile Neutropenia 159
Donor erythrocytosis induced by sorafenib treatment after allogeneic hematopoietic SCT in a patient with acute myeloid leukemia 158
Highly active antiretroviral therapy and allogeneic CD34(+) peripheral blood progenitor cells transplantation in an HIV/HCV coinfected patient with acute myeloid leukemia 156
New and old monoclonal antibodies for the treatment of chronic lymphocytic leukemia 151
Chronic lymphocytic leukemia with eyelid involvement responding to alemtuzumab. 151
Intralesional administration of rituximab for treatment of CD20 positive orbital lymphoma: Safety and efficacy evaluation. 151
The use of low-dose alemtuzumab in pretreated B-cell chronic lymphocytic leukemia. Leukemia. 150
Low incidence of secondary neoplasia after autotransplantation for lymphoproliferative disease: the role of pre-transplant therapy 150
Role of (18)F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients 148
Work related acute leukemia and mucor mycosis in a boat-builder 146
Role of 18F-FDG PET-CT for evaluating the response to reduced-intensity conditioning allogeneic transplant in heavily pre-treated patients with chronic lymphocytic leukemia: preliminary results in nine patients. 145
A T cell lymphoblastic lymphoma with mucormycosis as unusual etiology of acute cerebral ischemia 144
Carbapenemase-producingKlebsiella pneumoniaeand Hematologic Malignancies 143
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication 142
EXTREME THROMBOCYTOSIS IN CHRONIC MYELOID LEUKEMIA IN THE ERA OF TYROSINE KINASE INHIBITORS 141
Sorafenib for refractory FMS-like tyrosine kinase receptor-3 (FLT3/ITD+) acute myeloid leukemia after allogenic stem cell transplantation 140
Clinical reversible myelopathy in T-cell lymphoblastic lymphoma treated with nelarabine and radiotherapy: report of a case and review of literature of an increasing complication. 139
Hyperleukocytosis and leukostasis: management of a medical emergency 138
Oral fludarabine and cyclophosphamide as front-line chemotherapy in patients with chronic lymphocytic leukemia. The impact of biological parameters in the response duration 137
AB0 type does not affect platelet engraftment after autologous peripheral blood stem cell transplant in a series of 249 hematologic patients 137
Influence of the JAK2 V617F mutation and inherited thrombophilia on the thrombotic risk among patients with essential thrombocythemia 137
Prospective evaluation of epstein-barr virus reactivation after stem cell transplantation: association with monoclonal gammopathy. 136
H1N1 Influenza among Hematological Patients: Monocentric Influenza Cases from 2011 to 2016 136
Efficacy of Ceftazidime-avibactam Salvage Therapy in Patients with Infections Caused by KPC-producing Klebsiella pneumoniae 136
revalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience. 135
Neurologic improvement after peripheral blood stem cell transplantation in poems 134
Dasatinib as first-line treatment for adult patients with Philadelphia chromosome-positive acute lymphoblastic leukemia 132
Hyperleukocytosis and leukostasis: management of a medical emergency 132
The role of MTHFR and RFC1 polymorphisms on toxicity and outcome of adult patients with hematological malignancies treated with high-dose methotrexate followed by leucovorin rescue 131
Role of fecal calprotectin as biomarker of gastrointestinal GVHD after allogeneic stem cell transplantation 131
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 131
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 128
MTHFR polymorphisms involved in vitamin B12 deficiency associated with atrophic gastritis 127
Invasive fungal infections in chronic lymphoproliferative disorders: A monocentric retrospective study 127
Extramedullary Involvement in Acute Myeloid Leukemia. A Single Center Ten Years' Experience 126
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 126
Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias 125
Allogeneic Hemopoietic Stem Cell Transplantation for Myelofibrosis: 2021 125
Autologus stem cell transplantation as bridging rherapy followed by CD19 Car-T cells in relapsed refractory large B cell lymphoma 125
Prevalence, characteristics and management of occult hepatitis B virus infection in patients with chronic lymphocytic leukemia: a single center experience 124
Treatment of primary plasma cell leukemia with high doses of cyclophosphamide, bortezomib, and dexamethasone followed by double autologous HSCT 124
Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience 122
Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Philadelphia Positive Acute Lymphoblastic Leukemia in the Era of Tyrosine Kinase Inhibitors. A Registry-Based Study of the Italian Blood and Marrow Transplantation Society (Gitmo) 122
Long-term follow up of frontline therapy with fludarabine and cyclophosphamide in chronic lymphocytic leukemia: impact of biological parameters on clinical outcome 121
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 121
Autologous stem cell transplantation as bridging therapy followed by CD19 CAR-T cells in relapsed-refractory large B cell lymphoma. 121
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 120
Outcomes of Off the Shelf Outer Branched Versus Inner Branched Endografts in the Treatment of Thoraco-Abdominal Aortic Aneurysm in the B.R.I.O. (BRanched Inner – Outer) Study Group 119
Peripherally inserted central catheters (PICCs) in the management of oncohematological patients submitted to autologous stem cell transplantation 119
Reduced-intensity conditioning allogeneic transplant in heavily pre-treated chronic lymphocytic leukaemia patients: a single centre experience 118
Fecal but not serum calprotectin is a potential marker of GVHD after stem cell transplantation. 118
High-dose glucocorticoids plus Ofatumumab in fludarabine/alemtuzumab-resistant B-cell chronic lymphocytic leukemia 117
Clonal evolution in therapy-related neoplasms 117
Inline and offline extracorporeal photopheresis: Device performance, cell yields and clinical response 117
Molecular characterization of adenovirus from clinical samples through analysis of the hexon and fiber genes 115
Non-tunnelled central venous catheters in adult stem cell transplantation recipients: an effective option 114
Twenty years of unrestricted hematopoietic stem cell collection and storage: impact of Joint Accreditation Committee International Society for Cellular Therapy Europe standards implementation on stem cell storage policy and resource utilization 114
Coronavirus disease 2019 pandemic and allogeneic hematopoietic stem cell transplantation: a single center reappraisal 114
Endothelial activation predicts disseminated intravascular coagulopathy, cytokine release syndrome and prognosis in patients treated with anti-CD19 CAR-T 113
Eltrombopag for the treatment of poor graft function following allogenic stem cell transplant: a retrospective multicenter study 113
The sac evolution imaging follow-up after endovascular aortic repair: An international expert opinion-based Delphi consensus study 111
Molecular characterization of adenovirus from clinical samples through analysis of the hexon and fiber genes 111
Drug resistance and BCR-ABL kinase domain mutations in philadelphia chromosome-positive acute lymphoblastic leukemia from the imatinib to the second-generation tyrosine kinase inhibitor era: The main changes are in the type of mutations, but not in the frequency of mutation involvement 110
Invasive fungal infections in chronic lymphoproliferative disorders: a monocentric retrospective study 109
Full donor chimerism after allogeneic hematopoietic stem cells transplant for myelofibrosis: The role of the conditioning regimen 109
CAR-T Cell Therapy in B-Cell Acute Lymphoblastic Leukemia 108
Bloodstream infections caused by Klebsiella pneumoniae in onco-hematological patients: clinical impact of carbapenem resistance in a multicentre prospective survey 107
Clinical effects of driver somatic mutations on the outcomes of patients with myelodysplastic syndromes treated with allogeneic hematopoietic stem-cell transplantation 107
Reduction of hospitalization and transfusion support in patients with acute promyelocytic leukemia treated with arsenic trioxide plus all-trans retinoic acid compared to chemotherapy plus all-trans retinoic acid 107
Role of flow-cytometric immunophenotyping in prediction of BCR/ABL1 gene rearrangement in adult B-cell acute lymphoblastic leukemia 107
Allogeneic hematopoietic stem cell transplantation in therapy-related myeloid neoplasms (t-MN) of the adult: Monocentric observational study and review of the literature 105
Totale 17.939
Salva come PNG Salva come JPEG
Categoria #
all - tutte 169.094
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 169.094
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.151 0 0 0 0 0 109 139 62 291 90 386 74
2021/20222.628 249 128 75 139 162 78 66 390 140 179 507 515
2022/20235.174 754 661 414 708 373 621 263 337 571 183 196 93
2023/20244.039 124 853 194 210 218 561 243 157 165 271 499 544
2024/20258.340 429 341 649 566 591 289 323 348 1.116 793 1.591 1.304
2025/20269.594 2.735 615 1.209 1.737 2.585 713 0 0 0 0 0 0
Totale 38.321